Wei Xia Ang

855 total citations
8 papers, 660 citations indexed

About

Wei Xia Ang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wei Xia Ang has authored 8 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Immunology. Recurrent topics in Wei Xia Ang's work include CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (2 papers) and Nanoparticle-Based Drug Delivery (1 paper). Wei Xia Ang is often cited by papers focused on CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (2 papers) and Nanoparticle-Based Drug Delivery (1 paper). Wei Xia Ang collaborates with scholars based in Singapore, Italy and United Kingdom. Wei Xia Ang's co-authors include Cheryl M. Koh, Ernesto Guccione, Marco Bezzi, Soo‐Yong Tan, Keng Boon Wee, Florence Gay, Motomi Osato, Muthafar Al‐Haddawi, Diana Low and Arianna Sabò and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Biomaterials.

In The Last Decade

Wei Xia Ang

8 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Xia Ang Singapore 8 409 197 117 81 62 8 660
Chongkui Sun China 13 337 0.8× 192 1.0× 125 1.1× 57 0.7× 124 2.0× 16 621
Mansooreh Jaberipour Iran 14 232 0.6× 208 1.1× 117 1.0× 33 0.4× 72 1.2× 31 592
Hyo Won Chang South Korea 16 477 1.2× 183 0.9× 64 0.5× 38 0.5× 222 3.6× 33 732
Se Jin Oh South Korea 15 359 0.9× 190 1.0× 162 1.4× 20 0.2× 70 1.1× 22 601
Jean Claude Monboisse France 9 280 0.7× 181 0.9× 81 0.7× 30 0.4× 223 3.6× 13 628
He Ren China 16 363 0.9× 313 1.6× 162 1.4× 35 0.4× 281 4.5× 20 726
Ethan A. Kohn United States 9 516 1.3× 402 2.0× 98 0.8× 19 0.2× 88 1.4× 10 803
Nicole Rufo Belgium 9 188 0.5× 233 1.2× 309 2.6× 47 0.6× 28 0.5× 10 615
Yuebo Gan United States 16 410 1.0× 187 0.9× 25 0.2× 102 1.3× 112 1.8× 20 686
Caroline Contat Switzerland 5 381 0.9× 169 0.9× 222 1.9× 31 0.4× 274 4.4× 5 715

Countries citing papers authored by Wei Xia Ang

Since Specialization
Citations

This map shows the geographic impact of Wei Xia Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xia Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xia Ang more than expected).

Fields of papers citing papers by Wei Xia Ang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xia Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xia Ang. The network helps show where Wei Xia Ang may publish in the future.

Co-authorship network of co-authors of Wei Xia Ang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xia Ang. A scholar is included among the top collaborators of Wei Xia Ang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xia Ang. Wei Xia Ang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zhang, Xi, Wei Xia Ang, Yu Yang Ng, et al.. (2022). A CD123-Specific Chimeric Antigen Receptor Augments Anti-Acute Myeloid Leukemia Activity of Vγ9Vδ2 T Cells. Immunotherapy. 14(5). 321–336. 7 indexed citations
2.
Ang, Wei Xia, Yu Yang Ng, Lin Xiao, et al.. (2020). Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts. Molecular Therapy — Oncolytics. 17. 421–430. 49 indexed citations
3.
Bae, Ki Hyun, Atsushi Yamashita, Wei Xia Ang, et al.. (2017). Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. Biomaterials. 148. 41–53. 88 indexed citations
4.
Ang, Wei Xia, Qiang Li, Shouhui Du, et al.. (2017). Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis. Oncotarget. 8(8). 13545–13559. 92 indexed citations
5.
Ang, Wei Xia, Ying Zhao, Chunxiao Wu, et al.. (2016). Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy. Scientific Reports. 6(1). 32–34. 13 indexed citations
6.
Koh, Cheryl M., Ekta Khattar, Shi Chi Leow, et al.. (2015). Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. Journal of Clinical Investigation. 125(5). 2109–2122. 126 indexed citations
7.
Koh, Cheryl M., Marco Bezzi, Diana Low, et al.. (2015). MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature. 523(7558). 96–100. 266 indexed citations
8.
Chew, Ting Gang, Chanchao Lorthongpanich, Wei Xia Ang, Barbara B. Knowles, & Davor Solter. (2012). Symmetric cell division of the mouse zygote requires an actin network. Cytoskeleton. 69(12). 1040–1046. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026